Hanger Orthopedic Group Inc.’s (HGR) share price has entered into oversold territory with a stochastic value of 10.35. The Zacks Consensus Estimate on the company’s full-year earnings has climbed 3 cents over the past month to $1.06 per share. Hanger Orthopedic Group is a Zacks #2 Rank (“Buy") company.

"HGR" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Hanger Orthopedic Group, Inc. (HGR) yesterday reported financial results for the third quarter of fiscal 2009 after market close. Earnings per share were 30 cents, beating the Zacks Consensus Estimate of 27 cents and the year-ago earnings of 23 cents. Sales Net sales for the quarter increased 7.6% year over year to $192.3 million. Growth can be primarily attributed to higher same-center sales of patient care centers, higher demand for the company’s distribution segment and acquisitions. Patient-care services contributed approximately 88% to total sales while the remaining came from the distribution segment. Margins Gross margin declined 70 basis points (bps) year over year to 69.4% in the reported quarter due to higher cost of raw materials. However, strong sales and the company’s expense management initiatives helped it to increase operating and net margins. Both operating and net margins increased 100 bps year over year ...

The global medical devices industry is fairly large and is valued at roughly $223 billion, with the U.S. accounting for approximately 41%. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT. In the medical devices space, we recommend that investors focus on companies providing life-sustaining products. These companies provide a strong recurring stream of revenues as patients are unable to forego these products. Furthermore, investors should allocate funds to companies with high-earnings-quality profiles. Large companies with a wide portfolio of products are also better poised for good returns. These companies are capable of withstanding the current economic recession. Another area which is interestingly poised for growth these days is Healthcare IT. The landscape has changed since the Obama Administration passed a health care stimulus package to encourage hospitals and physicians practices to modernize their health record keeping. ...

For Immediate Release

Chicago, IL – October 12, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Hanger Orthopedic Group, Inc. (HGR), Orthofix International NV (OFIX), Conmed Corporation (CNMD), Exactech Inc. (EXAC) and Owens & Minor Inc. (OMI).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday’s Analyst Blog:

Hanger on Acquisition Spree

Hanger Orthopedic Group, Inc. (HGR) recently made three acquisitions totaling $10.7 million in annual net revenues. These acquisitions are: Creative Orthotics & Prosthetics, Inc.; Custom Orthopedics of Wyoming; and certain orthotics and prosthetics assets from the Hospital of

...

Hanger Orthopedic Group, Inc. (HGR) recently made three acquisitions totaling $10.7 million in annual net revenues. These acquisitions are: Creative Orthotics & Prosthetics, Inc.; Custom Orthopedics of Wyoming; and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania. These acquisitions will enable Hanger to add patient care centers to its existing markets in New York, Wyoming and Pennsylvania. Hanger will fund these acquisitions from internally generated cash flows. It is estimated that the acquisitions will be accretive to Hanger’s earnings once the integration process is over. The acquisitions strengthen Hanger’s leadership position in the orthotic and prosthetic (O&P) market and bolster its top-line. Hanger Orthopedic Group, based in Bethesda, MD, provides orthotic and prosthetic patient care services through its 671 patient care centers in the U.S. The company operates through four business units: patient care, distribution, Linkia and Innovative Neurotronics....

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

America Movil SAB de CV (AMX) America's Car-Mart Inc (CRMT) ATC Technology Corp (ATAC) ATMI Inc (ATMI) AXA (AXA) BHP Billiton Ltd (BHP) BlackRock Inc (BLK) Brush Engineered Material (BW) Carter's Inc (CRI) The Corporate Executive Board Co (EXBD) Dynamex Inc (DDMX) First Midwest Bancorp Inc (FMBI) Forestar Group Inc (FOR) Hanger Orthopedic Group Inc (HGR) HF Financial Corp (HFFC) HLTH Corp (HLTH) Kirkland's Inc (KIRK) ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

ATC Technology Corp (ATAC) Autoliv Inc (ALV) The Boston Beer Company Inc (SAM) Brigham Exploration Co (BEXP) Cymer Inc (CYMI) Deutsche Bank AG (DB) Expedia Inc (EXPE) Hanger Orthopedic Group Inc (HGR) Inergy Holdings LP (NRGP) ITT Corp (ITT) Joy Global Inc (JOYG) Limited Brands Inc (LTD) Lincoln Educational Services Corp (LINC) Lithia Motors Inc (LAD) Lorillard Inc (LO) Maidenform Brands Inc (MFB) Methode Electronics Inc (MEI) ...

NuVasive, Inc. (NUVA) is one of the top-performing Zacks #1 Rank companies on Wednesday with shares that have gained approximately 6.2%.

In late July, NUVA released its second-quarter report, which included better-than-expected EPS and a raised full-year guidance. Earnings estimates remain well above levels from 2 months ago.

The company is part of the Medical Products industry. The Zacks #1 Rank List includes 2 other companies from this space: Hanger Orthopedic Group, Inc. (HGR) and Micrus Endovascular Corporation (MEND).

NUVA is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. Volume today is about 413,000 shares; above the daily average of 391,000.

Earnings Estimates

The Zacks Consensus Estimate for this year is currently 26 cents per share, marking a 116% surge in the last 2 months from 12 cents per share.

...

Fossil, Inc. (FOSL) has been cutting costs and inventory as it rides out the rough retail environment. The company surprised on second quarter Zacks Consensus Estimates by 25% and is optimistic for the remainder of the year.

Even though there was an earnings surprise, sales fell 10.6% to $315.9 million from $353.2 million in the year ago period which reflected the difficult economic environment for retailers.

Sales declined 11.1% in the wholesale businesses but increased 21.1% in the direct to consumer segment, which includes the company's Internet site.

Rest of the Year Outlook

The company is more bullish on the fourth quarter, the holiday shopping season, than the third quarter where it will be easier for it to capitalize on gains from the Internet site.

Third quarter earnings per share are forecast between 38 and 42 cents and sales are expected to be in the range of negative

...

For Immediate Release

Chicago, IL – August 27, 2009 – Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.

The four highlighted picks are: Sepracor Inc (SEPR), Strayer Education, Inc. (STRA), Lubrizol Corp. (LZ) and Hanger Orthopedic Group Inc. (HGR).      Today, Zacks is promoting its ''Buy'' stock recommendations. Four daily picks are offered free at http://at.zacks.com/?id=5607

Zacks #1 Rank Stocks have nearly tripled the S&P 500 since 1988, producing an average annual return of +26%. Performance has been notable even during volatile and down times. For example, during the last bear market, 2000-2002, the market tumbled -37.6% – but Zacks #1 Rank stocks gained +43.8%.

Here is a

...